Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000845098> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W2000845098 endingPage "S316" @default.
- W2000845098 startingPage "S315" @default.
- W2000845098 abstract "Although muscarinic acetylcholine (mACh) receptors are expressed in trigeminal ganglia, it is still unknown whether mACh receptors modulate glutamatergic transmission from primary afferents onto medullary dorsal horn neurons. In this study, we have addressed the cholinergic modulation of primary afferent glutamatergic transmission using a conventional whole cell patch clamp technique. Glutamatergic excitatory postsynaptic currents (EPSCs) were evoked from primary afferents by electrical stimulation of trigeminal tract and monosynaptic EPSCs were recorded from medullary dorsal horn neurons of rat horizontal brain stem slices. Muscarine and ACh reversibly and concentration-dependently decreased the amplitude of glutamatergic EPSCs and increased the paired-pulse ratio. In addition, muscarine reduced the frequency of miniature EPSCs without affecting the current amplitude, suggesting that muscarine acts presynaptically to decrease the probability of glutamate release onto medullary dorsal horn neurons. The muscarine-induced decrease of glutamatergic EPSCs was significantly occluded by methoctramine or AF-DX116, M2 receptor antagonists, but not pirenzepine, J104129 and MT-3, selective M1, M3 and M4 receptor antagonists. The muscarine-induced decrease of glutamatergic EPSCs was highly dependent on the extracellular Ca2+ concentration. Physostigmine and clinically available acetylcholinesterase inhibitors, such as rivastigmine and donepezil, significantly shifted the concentration–inhibition relationship of ACh for glutamatergic EPSCs. These results suggest that muscarine acts on presynaptic M2 receptors to inhibit glutamatergic transmission by reducing the Ca2+ influx into primary afferent terminals, and that M2 receptor agonists and acetylcholinesterase inhibitors could be, at least, potential targets to reduce nociceptive transmission from orofacial tissues." @default.
- W2000845098 created "2016-06-24" @default.
- W2000845098 creator A5000388464 @default.
- W2000845098 creator A5018330880 @default.
- W2000845098 creator A5042508849 @default.
- W2000845098 creator A5058053789 @default.
- W2000845098 creator A5067625215 @default.
- W2000845098 date "2003-10-01" @default.
- W2000845098 modified "2023-10-16" @default.
- W2000845098 title "P.2.083 Pilot study of the effects of rivastigmine in schizophrenia" @default.
- W2000845098 doi "https://doi.org/10.1016/s0924-977x(03)92036-0" @default.
- W2000845098 hasPublicationYear "2003" @default.
- W2000845098 type Work @default.
- W2000845098 sameAs 2000845098 @default.
- W2000845098 citedByCount "2" @default.
- W2000845098 crossrefType "journal-article" @default.
- W2000845098 hasAuthorship W2000845098A5000388464 @default.
- W2000845098 hasAuthorship W2000845098A5018330880 @default.
- W2000845098 hasAuthorship W2000845098A5042508849 @default.
- W2000845098 hasAuthorship W2000845098A5058053789 @default.
- W2000845098 hasAuthorship W2000845098A5067625215 @default.
- W2000845098 hasConcept C112592302 @default.
- W2000845098 hasConcept C169760540 @default.
- W2000845098 hasConcept C170493617 @default.
- W2000845098 hasConcept C185592680 @default.
- W2000845098 hasConcept C2776961477 @default.
- W2000845098 hasConcept C2778616617 @default.
- W2000845098 hasConcept C2780648746 @default.
- W2000845098 hasConcept C2780841807 @default.
- W2000845098 hasConcept C33789571 @default.
- W2000845098 hasConcept C55493867 @default.
- W2000845098 hasConcept C61174792 @default.
- W2000845098 hasConcept C86803240 @default.
- W2000845098 hasConceptScore W2000845098C112592302 @default.
- W2000845098 hasConceptScore W2000845098C169760540 @default.
- W2000845098 hasConceptScore W2000845098C170493617 @default.
- W2000845098 hasConceptScore W2000845098C185592680 @default.
- W2000845098 hasConceptScore W2000845098C2776961477 @default.
- W2000845098 hasConceptScore W2000845098C2778616617 @default.
- W2000845098 hasConceptScore W2000845098C2780648746 @default.
- W2000845098 hasConceptScore W2000845098C2780841807 @default.
- W2000845098 hasConceptScore W2000845098C33789571 @default.
- W2000845098 hasConceptScore W2000845098C55493867 @default.
- W2000845098 hasConceptScore W2000845098C61174792 @default.
- W2000845098 hasConceptScore W2000845098C86803240 @default.
- W2000845098 hasLocation W20008450981 @default.
- W2000845098 hasOpenAccess W2000845098 @default.
- W2000845098 hasPrimaryLocation W20008450981 @default.
- W2000845098 hasRelatedWork W1702631555 @default.
- W2000845098 hasRelatedWork W1734214239 @default.
- W2000845098 hasRelatedWork W1991270934 @default.
- W2000845098 hasRelatedWork W2003890949 @default.
- W2000845098 hasRelatedWork W2043112375 @default.
- W2000845098 hasRelatedWork W2043869808 @default.
- W2000845098 hasRelatedWork W2073884106 @default.
- W2000845098 hasRelatedWork W2084277664 @default.
- W2000845098 hasRelatedWork W2129039188 @default.
- W2000845098 hasRelatedWork W2465989179 @default.
- W2000845098 hasVolume "13" @default.
- W2000845098 isParatext "false" @default.
- W2000845098 isRetracted "false" @default.
- W2000845098 magId "2000845098" @default.
- W2000845098 workType "article" @default.